SBFM
SBFM
NASDAQ · Biotechnology

Sunshine Biopharma Inc

$1.20
+0.05 (+4.35%)
As of Feb 8, 2:31 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,279.2% upside
Low Target $10.07
Average Target $16.55
High Target $19.24
Current Price $1.20
Current
$1.20
Target
$16.55
$10.07 $16.55 avg $19.24
Scenario Analysis
Bear Case
$10.07
739.2%
Low target
Base Case
$16.55
+1,279.2%
Avg target
Bull Case
$19.24
+1,503.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$17.78
-93.3% from high
52-Week Low
$10.43
+-88.5% from low
Target vs 52W High
$16.55
-6.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%